Skip to main content
SpringerLink
Log in

Clinical Trials Report

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Conclusions

Improvement in insulin sensitivity with administration of rosiglitazone resulted in improved histologic markers of NASH. This observation suggests that insulin resistance contributes to the development of NASH and that improving insulin sensitivity may be an important treatment for this liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Bruce R. Bacon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bacon, B.R. Clinical Trials Report. Curr Gastroenterol Rep 6, 6 (2004). https://doi.org/10.1007/s11894-004-0019-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-004-0019-0

Keywords

Search

Navigation